Cargando…
Outcome of patients with nonmetastatic muscle‐invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin‐based chemotherapy and/or radiotherapy: a retrospective analysis
Transurethral resection of bladder tumor (TURBT), radiotherapy, chemotherapy, or combinations can be used in patients with muscle‐invasive bladder cancer (MIBC) not undergoing cystectomy. Nevertheless, unfitness for cystectomy is frequently associated with unfitness for other therapeutic modalities....
Autores principales: | Bamias, Aristotle, Tsantoulis, Petros, Zilli, Thomas, Papatsoris, Athanasios, Caparrotti, Francesca, Kyratsas, Christos, Tzannis, Kimon, Stravodimos, Kostas, Chrisofos, Michael, Wirth, Gregory J., Skolarikos, Andreas, Mitropoulos, Dionysios, Constantinides, Constantinos A., Deliveliotis, Charalambos, Iselin, Christophe E., Miralbell, Raymond, Dietrich, Pierre‐Yves, Dimopoulos, Meletios A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924368/ https://www.ncbi.nlm.nih.gov/pubmed/27004619 http://dx.doi.org/10.1002/cam4.685 |
Ejemplares similares
-
ERCC1 19007 Polymorphism in Greek Patients with Advanced Urothelial Cancer Treated with Platinum-Based Chemotherapy: Effect of the Changing Treatment Paradigm: A Cohort Study by the Hellenic GU Cancer Group
por: Bamias, Aristotelis, et al.
Publicado: (2021) -
Referral for “Neoadjuvant Chemotherapy” for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and Outcomes
por: Dellis, Athanasios, et al.
Publicado: (2021) -
Management of stent-related symptoms with the use of α-blockers: A meta-analysis
por: Deliveliotis, Konstantinos, et al.
Publicado: (2019) -
Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group
por: Pistamaltzian, Nikolaos, et al.
Publicado: (2016) -
Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study
por: Bamias, Aristotelis, et al.
Publicado: (2022)